Title : Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.

Pub. Date : 1995 Jun

PMID : 7771416






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Besides liver transplantation for patients with end-stage cirrhotic liver disease and endoscopic therapy for patients with dominant extrahepatic bile duct strictures, recent studies have also shown promising results of drug therapy with ursodeoxycholic acid in the treatment of PSC. Ursodeoxycholic Acid PSC Homo sapiens
2 The purpose of this article is to summarize our current knowledge of the immunogenetic factors in the pathogenesis of PSC and to present support for drug therapy with ursodeoxycholic acid in the treatment of PSC. Ursodeoxycholic Acid PSC Homo sapiens
3 The purpose of this article is to summarize our current knowledge of the immunogenetic factors in the pathogenesis of PSC and to present support for drug therapy with ursodeoxycholic acid in the treatment of PSC. Ursodeoxycholic Acid PSC Homo sapiens
4 The genetic and immunological factors in the pathogenesis of PSC are outlined first, followed by a rationale of drug therapy with ursodeoxycholic acid in the treatment of PSC. Ursodeoxycholic Acid PSC Homo sapiens